tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
United Therapeutics announces first clinical xenotransplantation in EXPAND study
PremiumThe FlyUnited Therapeutics announces first clinical xenotransplantation in EXPAND study
3M ago
United Therapeutics price target raised to $587 from $569 at RBC Capital
Premium
The Fly
United Therapeutics price target raised to $587 from $569 at RBC Capital
3M ago
United Therapeutics price target raised to $525 from $500 at H.C. Wainwright
Premium
The Fly
United Therapeutics price target raised to $525 from $500 at H.C. Wainwright
3M ago
Strong Growth Potential and Strategic Initiatives Drive Buy Rating for United Therapeutics
PremiumRatingsStrong Growth Potential and Strategic Initiatives Drive Buy Rating for United Therapeutics
3M ago
United Therapeutics price target raised to $575 from $564 at Jefferies
Premium
The Fly
United Therapeutics price target raised to $575 from $564 at Jefferies
3M ago
United Therapeutics: Strong Growth Potential Amid Short-Term Volatility Supports Buy Rating
Premium
Ratings
United Therapeutics: Strong Growth Potential Amid Short-Term Volatility Supports Buy Rating
3M ago
United Therapeutics’ Promising Phase 3 Study on Inhaled Treprostinil for Pulmonary Fibrosis
PremiumCompany AnnouncementsUnited Therapeutics’ Promising Phase 3 Study on Inhaled Treprostinil for Pulmonary Fibrosis
3M ago
United Therapeutics’ AI-Driven Study: A Potential Game-Changer for Pulmonary Hypertension Diagnosis
Premium
Company Announcements
United Therapeutics’ AI-Driven Study: A Potential Game-Changer for Pulmonary Hypertension Diagnosis
3M ago
United Therapeutics’ DeciPHer-ILD Study: A Closer Look at PH-ILD Patient Registry
Premium
Company Announcements
United Therapeutics’ DeciPHer-ILD Study: A Closer Look at PH-ILD Patient Registry
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100